Christoph Hüls

Chief Executive Officer at

Max-Planck-Innovation GmbH

Health Technology

Process Industries

Utilities

Profile

Christoph Hüls is currently the Co-Managing Director at Max-Planck-Innovation GmbH.
Previously, he held positions as the Chief Executive Officer at Protagen AG, Principal at Hoechst AG, Aventis SA, and Novartis AG, and as a Member-Supervisory Board at Trianel GmbH.

Christoph Hüls active positions

Companies	Position	Start
Max-Planck-Innovation GmbH Max-Planck-Innovation GmbH Miscellaneous Commercial ServicesCommercial Services Provides technology transfer from the research institutes of the Max Planck society	Chief Executive Officer	-

All active positions of Christoph Hüls

Former positions of Christoph Hüls

Companies	Position	End
Trianel GmbH Trianel GmbH Electric UtilitiesUtilities Distributes electricity	Director/Board Member	-
Hoechst AG Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products	Corporate Officer/Principal	-
NOVARTIS AG	Corporate Officer/Principal	-
Aventis SA Aventis SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and vaccines for preventative medicine	Corporate Officer/Principal	-
Protagen AG Protagen AG BiotechnologyHealth Technology Specializes in the development of novel diagnostic and companion diagnostic tests	Chairman	-

See the detail of Christoph Hüls's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies